Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book observes the idea of race as a false representation for the cause of disease. Race-based medicine, an emerging field in pharmacology, aims to create a specialty market based on racial groups. Within this market, the drug BiDil set a precedent in this area of medicine targeting African Americans as its first racial group. Consequently, selecting African Americans as a “starter group” led to ethical questions regarding the motive behind race-based medicine within the context of the larger treatment of blacks in American medical history. This book therefore links medicine and American…mehr
This book observes the idea of race as a false representation for the cause of disease. Race-based medicine, an emerging field in pharmacology, aims to create a specialty market based on racial groups. Within this market, the drug BiDil set a precedent in this area of medicine targeting African Americans as its first racial group. Consequently, selecting African Americans as a “starter group” led to ethical questions regarding the motive behind race-based medicine within the context of the larger treatment of blacks in American medical history. This book therefore links medicine and American eugenics, examines race-based medicine’s influence on the perception of the black body, traces the influence of BiDil’s approval on the resurgence of race-based medicine, and assesses the black church’s response to race-based medicine using black liberation theology as a means to social justice.
Dr. Kirk A. Johnson teaches at Seton Hall University and Berkeley College in New Jersey, US. He is a member of the American Society of Bioethics and Humanities and The New York Academy of Medicine. He serves as a member of the Atlantic Health Systems Bioethics Committee and was formerly Assistant Director of the Medical Humanities program at Drew University in Madison, New Jersey, US.
Inhaltsangabe
Chapter 1 Introduction.- Chapter 2 Race-Based Medicine.- Chapter 3 Maleficence toward the Minority Patient.- Chapter 4 Research, Race, and Profit.- Chapter 5 Black Theology and Reconciliation.- Chapter 6 Conclusion.- Bibliography.
Chapter 1 Introduction.- Chapter 2 Race-Based Medicine.- Chapter 3 Maleficence toward the Minority Patient.- Chapter 4 Research, Race, and Profit.- Chapter 5 Black Theology and Reconciliation.- Chapter 6 Conclusion.- Bibliography.
Chapter 1 Introduction.- Chapter 2 Race-Based Medicine.- Chapter 3 Maleficence toward the Minority Patient.- Chapter 4 Research, Race, and Profit.- Chapter 5 Black Theology and Reconciliation.- Chapter 6 Conclusion.- Bibliography.
Chapter 1 Introduction.- Chapter 2 Race-Based Medicine.- Chapter 3 Maleficence toward the Minority Patient.- Chapter 4 Research, Race, and Profit.- Chapter 5 Black Theology and Reconciliation.- Chapter 6 Conclusion.- Bibliography.
Rezensionen
"Medical Stigmata encourages readers to apply similar hermeneutics to clinical contexts, using scripture to challenge the determinist narratives that pervade medicine and its adjacent industries." (Audrey Farley, Marginalia, marginalia.lareviewofbooks.org, October 18, 2019)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/neu